Hualan Biological Engineering Inc.

China (People China (People's Republic)
Sector: Biotechnology
Ticker: 002007
ISIN: CNE000001JN8
Factsheet Factsheet

Profitability Analysis of Hualan Biological Engineering Inc. ( 002007 | CHN)

The Profitability Score is a relevant measure for the assessment of a stock attractiveness. Hualan Biological Engineering Inc. shows a Profitability Score of N/A.
The Profitability Score for Hualan Biological Engineering Inc. is lower than its peer group's. This means that Hualan Biological Engineering Inc. has a lower profitability than its peer group.

Valuation
EV/EBITDA LastEV/EBITDA(e) 2024EV/EBITDA NTM
Hualan Biological Engineering Inc.Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
Biotechnology-0.660.240.77
N/AN/AN/AN/A
China (People's Republic)15.2911.729.34
More...
Betanull
Levered betaUnlevered beta
1-YearN/AN/A
2-YearN/AN/A
3-YearN/AN/A
More...
Stock Perf excl. Dividends (in N/A)
002007N/ARel. Perf.
Year-to-DateN/AN/AN/A
1-WeekN/AN/AN/A
1-MonthN/AN/AN/A
1-YearN/AN/AN/A
3-YearN/AN/AN/A
5-YearN/AN/AN/A
More...
GPRV Analysis
GPRV® analysis is not available due to one of the
following reasons:
  • - Company is not covered by analysts (no estimates)
  • - Company is an insurance company
More...
International Peers - Hualan Biological Engineering Inc.
Company NameCtryMarket
Cap.
last (mUSD)
Hualan Biological Engin...CHNN/A
International Peers Median1.03
CureVac N.V.NLD1 001
Cerus CorporationUSA255
Repligen CorporationUSA7 039
Anhui Anke Biotechnolog...CHNN/A
Seagen Inc.USAN/A
Net Sales Chart
Created with Highcharts 4.1.7Millions CNY201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k2.5k5k7.5k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Hualan Biological Engineering Inc.
Created with Highcharts 4.1.710. Jun17. Jun24. Jun1. Jul-15%-10%-5%0%5%
More...

About Stock Profitability Analysis

Aggregated Profitability Score
In GPRV, the Aggregated Profitability Score is the average of the profitability indicators' scores.

EBIT Margin Historical
This is a weighted average of the Historical EBIT Margins.
Calculation: (using up to 5 years of historical data when available)
[EBIT Margin year N*5 + EBIT Margin year (N-1)*4 + EBIT Margin year (N-2)*3 + EBIT Margin year (N-3)*2 + EBIT Margin (N-4)] / 15

EBIT Margin NTM
This is an estimate for EBIT Margin over the Next Twelve Months.
Calculation:
EBIT NTM / Net Sales NTM using estimates consensus for EBIT and Net Sales

ROCE Historical
This is a weighted average of the Historical Returns On Capital Employed.
Calculation: (using up to 5 years of historical data when available)
[ROCE year N*5 + ROCE year (N-1)*4 + ROCE year (N-2)*3 + ROCE year (N-3)*2 + ROCE year (N-4)] / 15

ROE Last
ROE (Return on Equity) is one of the most widely used measures of how well a company is performing for its shareholders, as it indicates how much was earned for each unit invested by the owners. It is a relatively straightforward benchmark for investors to compare the company's use of its equity against other investments.
Calculation:
ROE=Net profit after preferred dividends (Last) / Average total equity for the last 2 years (in %)

Dividend Yield NTM
This is an estimate for Dividend Yield over the Next Twelve Months.
Calculation:
The median of dividend per share estimates divided by the last share price.